MetaCap

BriaCell Therapeutics Corp. Company Profile

NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.95-0.05 (-1.25%)

Market open · Delayed 15 min · as of Oct 8, 1:10 PM ET

BriaCell Therapeutics at a glance

BriaCell Therapeutics Corp. (NASDAQ: BCTX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. At a market capitalization of $35.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001610820, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

Company information

Legal name
BriaCell Therapeutics Corp.
Ticker
NASDAQ: BCTX
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
Canada
Market cap
$34.97M
SEC CIK
0001610820

Companies similar to BriaCell Therapeutics

BCTX peer companies
CompanyPrice% ChgMarket capCompare
IBOImpact BioMedical Inc.4.20-6.25%$35.88Mvs BCTX
GRDXGridAI Technologies Corp.4.76+15.50%$33.92Mvs BCTX
NNVCNanoViricides Inc.1.32-8.33%$33.69Mvs BCTX
ATNMActinium Pharmaceuticals Inc. (Delaware)1.070.00%$33.64Mvs BCTX
LITSLite Strategy Inc.1.20-5.91%$36.34Mvs BCTX
RMTIRockwell Medical Inc.8.08-1.76%$32.55Mvs BCTX
FLNAFilana Therapeutics Inc.0.7919-2.92%$38.26Mvs BCTX
NXTCNextCure Inc.6.65+1.37%$30.44Mvs BCTX

Related